Contract facts
NONERADIOPHARMACEUTICALS is a federal NONE award for 242-Network Contract Office 02 (36C242) held by Nuclear Diagnostic Products, Inc. Estimated value —. Related solicitation 36C24226Q0263.
Incumbent footprint
Public recordNuclear Diagnostic Products, Inc — $6.3M obligated across 23 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24226D0037?
36C24226D0037 (Radiopharmaceuticals) is a 242-Network Contract Office 02 (36C242) award with an estimated value of —, currently held by Nuclear Diagnostic Products, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C242-26-D-0037?
36C242-26-D-0037 is the dashed form of PIID 36C24226D0037 (Radiopharmaceuticals), held by Nuclear Diagnostic Products, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24226D0037?
242-Network Contract Office 02 (36C242) awarded 36C24226D0037 to Nuclear Diagnostic Products, Inc.
Who is the incumbent on 36C24226D0037?
Nuclear Diagnostic Products, Inc is the incumbent with $6.3M across 23 related awards in SCOUT’s public footprint.
When does Nuclear Diagnostic Products, Inc’s 36C24226D0037 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.